Vilchez is the first IRB Barcelona alumnus to receive the “Alumni of Excellence Award”. He obtained his PhD at the Institute in 2008 and now runs his own group at the CECAD-Cluster of Excellence in Cologne, Germany.
Los cambios en la regulación de dos genes explican la forma más evolucionada del sistema respiratorio de Drosophila a partir de un sistema más primitivo
Publicado en la revista Development
Vilchez se doctoró en el IRB Barcelona en 2008 y hace tres años que dirige su propio laboratorio en Alemania, donde ha obtenido una ERC Starting Grant
La segunda convocatoria para optar al galardón en 2017 se abrirá en otoño
Científicos del IRB Barcelona describen por primera vez cómo preparar un agregado de proteína beta amiloide con habilidad para perforar la membrana celular
No se conoce aún qué provoca la muerte de neuronas en Alzheimer así como el consiguiente deterioro cognitivo
Peter Jung was Postdoctoral Fellow in Eduard Batlle’s Colorectal Cancer lab between 2009 and 2015. Now he is Principal Investigator at the Institute of Pathology Ludwig-Maximilians-Universität in Munich. This institute is a partner site of the DKTK Cancer Consortium, coordinated by the German Cancer Research Center (DKFZ). “Life and science are an on-going learning process with new challenges to encounter with every new project,” he says.
Eva Novoa was one of the first students to complete a PhD in as part of the ”la Caixa”/IRB Barcelona International PhD Programme in Biomedicine. She was a PhD student at IRB Barcelona between 2008 and 2012. Six months ago, she moved to Sydney, Australia to join the Garvan Institute of Medical Research as a Senior Research Officer. She just received the Young Research Award from the Catalan Society for Biology.
La enfermedad de Kennedy genera atrofia progresiva de los músculos, afecta sólo a los hombres y se manifiesta entre los 40 y 50 años. No tiene ningún tratamiento específico.
Las células musculares y las neuronas motoras se mueren con el paso de los años porque acumulan dentro una proteína que los afectados tienen mutada.
Los investigadores del IRB Barcelona descubren que la proteína lleva incorporado un mecanismo que demora los efectos perniciosos de la mutación.
“I like new challenges, I like facing changes. I am not afraid to embark on a new adventure”. Academic Coordinator Patricia Nadal (Valencia, 1984) said these words in May when she left IRB Barcelona to become Programme Manager at the ”la Caixa” Foundation. After a little over six years at the Institute, she has moved on to run the international PhD Programme (INPhINIT) that the Foundation—an established partner of many activities launched by IRB Barcelona—is currently setting up. A specialist in Human Resources and Tourism, Patricia also combined her career at IRB Barcelona with postgraduate training in Human Resources and Management, a qualification she obtained in 2016.
How well does IRB Barcelona fare in addressing its employees' expectations when it comes to gender equality, inclusion and diversity? To answer this crucial question, a working group has been set up at the Institute. Its goal is to pave the way for the implementation of gender equality and diversity procedures and policies for all employees.
Histopathology Core Facility Manager Neus Prats is leading this working group. The group will soon give way to a proper Equality and Diversity Committee that will include members representing all IRB Barcelona's communities. The group currently includes Head of...
Fayna García (Las Palmas, 1979) did her doctoral thesis on the synthesis of peptides of biomedical interest at IRB Barcelona under the supervision of Fernando Albericio. Having finished her PhD in 2007, she is one of the first female doctoral students and alumni of the Institute. In 2008, she applied for an academic position at the Hokkaido University (HU) School of Life Sciences that was offered exclusively to female scientists. She would be later appointed Assistant Professor at the same University, a position that she still holds today. At the same time, she...